Merganser Biotech gets investment for iron overload therapeutics
Merganser Biotech, a drug licensing and development startup, has secured funding from a consortium that includes BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania and individual investors for its plan to develop hepcidin mimetic peptides for the treatment of diseases related to iron overload. The amount invested was not disclosed. Merganser signed an agreement for an […]